New Study Unveils Clues to ‘Exceptional’ Response in Metastatic Kidney Cancer Immunotherapy
Metastatic clear cell renal cell carcinoma (mccRCC), an aggressive type of kidney cancer, historically has presented limited treatment options. Immune checkpoint inhibitors, a form of immunotherapy, can lead to exceptional, durable responses (when...
9-Jan-2025 9:05 AM EST
Add to Favorites